NowenNeuroEM Therapeutics, Inc. Unclaimed
Tampa, Florida, United States
NeuroEM Therapeutics is a clinical-stage biotech developing non-invasive, drug-free approaches to reverse cognitive decline caused by Alzheimer's and other neurodegenerative diseases.
NeuroEM Therapeutics is a clinical-stage biotechnology company focused on non-drug, non-invasive therapies to reverse cognitive decline associated with Alzheimer's disease and other neurodegenerative conditions. Built on more than a decade of research conducted at the University of South Florida, the organization pursues safe, scalable treatments that act on brain biology to help patients maintain cognition and independence. The company describes Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) as a technology platform designed to influence neural proteins, immune balance, and energy production in brain cells, with the aim of slowing or reversing disease progression. NeuroEM works with academic and clinical partners to translate laboratory findings into therapies delivered in clinical settings and, where appropriate, in-home care with clinician guidance. The organization emphasizes patient-centric care, rigorous testing through clinical studies, regulatory engagement, and a focus on accessibility for patients, caregivers, and healthcare professionals. Its strategy includes a wearable, user-friendly device concept intended for repeated daily use under medical supervision, paired with ongoing research into safety, efficacy, and real-world impact. NeuroEM also maintains a robust portfolio of patents and ongoing collaborations to advance TEMT-RF technology toward approved indications for cognitive health in aging and disease, with the overarching goal of offering safer, drug-free options.
At NeuroEM Therapeutics®, our mission is to revolutionize the drug-free treatment of cognitive decline through our groundbreaking Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) technology.
What we offer
Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)
Provides innovative, drug-free treatment to combat cognitive decline in Alzheimer's patients.
www.neuroem.com/temt-rf-technologyMarket segments
Noninvasive neurostimulation for cognitive impairment
Devices and protocols that use electromagnetic or other noninvasive stimulation to improve cognitive function in Alzheimer's disease, mild cognitive impairment, and related disorders.
Wearable at-home neurological therapeutic devices
Wearable medical devices designed for regular in-home administration under clinical guidance to manage chronic neurological conditions and support cognitive health.
Device-based disease-modifying therapies for Alzheimer's and dementia
Medical devices intended to alter disease biology—targeting protein aggregation, neuroinflammation, or cellular energy—to slow or reverse neurodegenerative disease progression.
Clinical-stage investigational medical devices and research platforms
Platforms and devices undergoing formal clinical studies and regulatory interaction, used by academic and clinical partners for translational development and regulatory approval pathways.
More information about our offering
Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)
TEMT-RF is a non-drug, non-invasive brain treatment platform that uses radio-frequency energy to deliver Transcranial Electromagnetic Treatment. The platform aims to address cognitive decline by breaking up toxic protein oligomers, restoring immune balance in brain and blood, and boosting energy production in brain cells. It is delivered via a wearable device, including a lightweight cap designed for comfortable, at-home use, and is under clinical development, with FDA Breakthrough Device status awarded for treating Alzheimer's disease.
- Supports Cognitive HealthThis feature effectively collaborates multiple mechanisms to enhance cognitive health by addressing various aspects of cognitive decline.
- Offers Safe TreatmentThis approach eliminates the need for pharmaceuticals and surgical procedures, making it attractive for patients seeking less invasive options.
- Streamlines Regulatory PathAchieving Breakthrough Device status accelerates the pathway to market, ensuring a focus on rapid and safe treatment development for Alzheimer's.
- Proven EffectivenessClinical studies highlight the potential of TEMT-RF to reverse cognitive decline, providing evidence for its efficacy in treating Alzheimer's disease.
- Addresses Multiple MechanismsThis allows TEMT-RF to not only treat symptoms of Alzheimer's but potentially modify disease progression itself.
- Delivers Focused TreatmentShort pulses of energy are specifically designed to target the underlying causes of cognitive decline, enhancing the overall therapeutic impact.
- Ensures ConvenienceAllows patients to use the treatment in their daily routines, promoting compliance and ease of use.
- Structured Treatment ScheduleUsing a consistent schedule enhances treatment effectiveness and patient adherence.